A study followed more than 3,000 people over the age of 60 for eight years and found that this decline is not observed in women.
Researchers evaluated 21 language models, such as GPT and Gemini, and found that they all alter their discourse to align with the user’s bias, potentially functioning as echo chambers.
Research shows that the AMOC, a system fundamental to the Earth’s climate, has undergone sudden changes in the past, driven by climate shifts similar to those we are experiencing now.
Work by researchers at a FAPESP-supported research center may open promising avenues for applications in photocatalysis, optoelectronics, and photonics.
Startup develops a sensor that measures interactions between molecules with high precision, which can reduce the time and costs of discovering drug candidates.
A research group from the University of São Paulo analyzed over 1,600 articles and found that research increased by 9.5% annually between 1974 and 2025. The authors advocate for regionalized solutions and public policies to bridge the gap between evidence and implementation.
Study involving the Center for the Development of Functional Materials was published in the journal Ceramics International.
Research on sickle cell anemia spurred the development of genetic technologies, but there is an urgent need to democratize access to modern therapies, noted French hematologist Jacques Elion at a conference hosted by FAPESP.
Study reveals that tapirs, peccaries, agoutis, and deer act as true ecosystem engineers by reducing soil acidity, increasing diversity, and accelerating the decomposition of organic matter in the forest.
Research conducted on mice provides experimental evidence that exposure to PM2.5, a main component of urban air pollution, increases oxidative stress, intensifies inflammatory responses, and worsens the destruction of periodontal tissues.
Understanding how Trypanosoma cruzi manipulates its own RNA to alter protein production and invade the host could lead to new therapeutic approaches against the disease.
Startup develops a sensor that measures interactions between molecules with high precision, which can reduce the time and costs of discovering drug candidates.